Asia-Pacific In Vitro Diagnostics Market on Track to Reach $36.02 Billion by 2031 ‘Asia-Pacific In Vitro Diagnostics Market by Offering (Kits, Software), Technology (Immunoassay, Molecular Diagnostics [PCR, NGS, Microarray], Rapid Tests, Biochemistry), Application (Infectious Diseases, Oncology), Diagnostic Approach - Forecast to 2031.’ Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5750 Key Players The key players operating in the Asia-Pacific IVD market are Abbott Laboratories (U.S.), Becton, Dickinson and Company (U.S.), Sysmex Corporation (Japan), bioMérieux SA (France), Bio-Rad Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Seegene Inc. (South Korea), Illumina, Inc. (U.S.), Shenzhen Mindray Bio-Medical Electronics Co., Ltd (China), Siemens Healthineers AG (Germany), Thermo Fisher Scientific Inc. (U.S.), QuidelOrtho Corporation (U.S.), and Agilent Technologies Inc. (U.S.). Asia-Pacific IVD Market: Future Outlook The Asia-Pacific IVD market is segmented by Offering (Kits & Reagents, Instruments, and Software & Services), Technology (Immunoassay/Immunochemistry, Biochemistry/Clinical Chemistry, Molecular Diagnostics, Point of Care (POC) Diagnostics, Whole Blood Glucose Monitoring, Microbiology, Hematology, Coagulation/Hemostasis, Urinalysis, and Other Technologies), Application (Infectious Diseases, Oncology, Diabetes, Cardiology, Nephrology, Autoimmune Disorders, and Other Applications), Diagnostic Approach (Lab Testing, OTC/Self-testing, and Point of Care Testing), and End User (Diagnostic Laboratories, Hospitals & Clinics, Home Healthcare, and Other End Users), and Countries. The study also evaluates industry competitors and analyzes their market share at the country level. 𝐇𝐚𝐯𝐞 𝐚𝐧𝐲 𝐪𝐮𝐞𝐫𝐲 𝐀𝐒𝐊 𝐄𝐗𝐏𝐄𝐑𝐓 : https://www.meticulousresearch.com/speak-to-analyst/cp_id=5750 by Offering • Kits & Reagents • Instruments • Software & Services by Technology • Molecular Diagnostics o Polymerase Chain Reaction (PCR) o Hybridization o Isothermal Nucleic Acid Amplification Technology o DNA Sequencing & Next-generation Sequencing o Microarrays o Mass Spectrometry o Other Molecular Diagnostic Technologies • Point of Care (PoC) Diagnostics o Lateral Flow Assays/Rapid Tests o POC Molecular Diagnostics o Other PoC Products • Immunoassay/Immunochemistry o Enzyme-linked Immunosorbent Assays (ELISA) o Radioimmunoassays o Western Blotting o Enzyme-Linked Immunospot Assays o Immunohistochemistry (IHC) • Biochemistry/Clinical Chemistry o Metabolic Panel o Electrolyte Panel o Liver Panel o Lipid Profile o Renal Profile o Thyroid Function Panel • Whole Blood Glucose Monitoring • Microbiology • Hematology • Coagulation/Hemostasis • Urinalysis • Other IVD Technologies by Application • Infectious Diseases o COVID-19 Testing o Sexually Transmitted Diseases (STD) Testing o Healthcare-associated Infections (HAIs) o Hepatitis o HIV o Tropical Diseases o Respiratory Infections (Excluding Influenza) o Influenza o Other Infectious Diseases • Oncology • Diabetes • Cardiology • Nephrology • Autoimmune Disorders • Other Applications by Diagnostic Approach • Lab Testing • OTC/Self-testing • Point of Care Testing by End User • Diagnostic Laboratories • Hospitals & Clinics • Home Healthcare • Other End Users by Country/Region • China • Japan • India • Australia • South Korea • Thailand • Singapore • Indonesia • Rest of Asia-Pacific Browse Here: https://www.meticulousresearch.com/product/asia-pacific-in-vitro-diagnostics-market-5750 Geographic Review Key questions answered in the report: • Which are the high-growth market segments in terms of offering, technology, application, diagnostic approach, end user, and country? • What was the historical market for IVD testing in Asia-Pacific? • What are the market forecasts and estimates for the period 2024–2031? • What are the major drivers, restraints, challenges, and opportunities in the Asia-Pacific IVD market? • Who are the major players in the Asia-Pacific IVD market? Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5750 ContactUs: MeticulousResearch® Email- [email protected] ContactSales-+1-646-781-8004 Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research

Leading the Genomic Revolution: A Comprehensive Look at the Top Companies in the North America NGS Automation Market ‘North America NGS Automation Market by Product {Workstations, Consumables}, Sequencing Type {Whole Genome, Exome, Targeted Genome}, Application {Drug Discovery, Diagnostics, Oncology}, End User {Hospitals, Pharmaceutical, Diagnostic Labs} - Forecast to 2030.’ https://www.meticulousresearch.com/product/north-america-ngs-automation-market-5736 Here are some companies that were notable in the NGS industry: 1. Agilent Technologies, Inc. (U.S.), 2. Danaher Corporation (U.S.), 3. Eppendorf AG (Germany), 4. Hamilton Company (U.S.), 5. PerkinElmer, Inc. (U.S.), 6. Tecan Group Ltd. (Switzerland), 7. BRAND GMBH + CO KG (Germany), 8. Hudson Robotics (U.S.), 9. SPT Labtech (U.K.), 10. Thermo Fisher Scientific Inc. (U.S.), 11. F. Hoffmann-La Roche Ltd. (Switzerland). According to this latest publication from Meticulous Research®, the North America NGS automation market is expected to register a CAGR of 14% from 2023 to reach $776.1 million by 2030. The growth of the North America NGS automation market is attributed to the increasing prevalence of cancer cases, rising demand for NGS automation in laboratories, growing demand for optimized & streamlined workflows, and increasing pharmaceutical R&D investments & healthcare expenditures. Furthermore, the rising application of NGS technology and collaborations between vendors to develop library preparation protocols are expected to offer immense growth opportunities for market expansion 𝐆𝐞𝐭 𝐁𝐮𝐬𝐢𝐧𝐞𝐬𝐬 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐒𝐭𝐮𝐝𝐲, 𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐏𝐃𝐅- North America NGS Automation Market - Opportunity Analysis and Industry Forecast (2023-2030) |Download Sample Report (https://www.meticulousresearch.com/download-sample-report/cp_id=5736) Scope of the Report: North America NGS Automation Market Assessment, by Product • Workstations/Robotic Platforms • Reagents & Consumables North America NGS Automation Market Assessment, by Sequencing Type • Whole Genome Sequencing • Whole Exome Sequencing • Targeted Genome Sequencing • Other Sequencing Types (Note: The sequencing type comprises degradome sequencing, chromatin immunoprecipitation (ChIP) sequencing, and methylation sequencing) North America NGS Automation Market Assessment, by Application • Drug Discovery • Clinical Diagnostics o Reproductive Health Diagnostics o Oncology Diagnostics o Infectious Disease Diagnostics o Other Clinical Diagnostics Applications • Other Applications North America NGS Automation Market Assessment, by End User • Pharmaceutical & Biotechnology Companies • Hospitals & Diagnostic Laboratories • Academics & Research Institutes • Other End Users (Note: The other end users comprise forensic laboratories & security agencies, the food industry, and the agriculture industry) North America NGS Automation Market Assessment, by Country • U.S. • Canada Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5736Key questions answered in the report: • What are the high-growth market segments regarding the product, sequencing type, application, end user, and country? • What was the historical market for North America NGS automation? • What are the market forecasts and estimates for 2023–2030? • What are the major drivers, restraints, challenges, and opportunities in the North America NGS automation market? • Who are the major players in the North America NGS automation market? Need more information? Meticulous Research®’s new report covers each of these companies in much more detail, providing analysis on the following: • Recent financial performance • Key products • Significant company strategies • Partnerships and acquisitions The Comprehensive report provides global market size estimates, market share analysis, revenue numbers, and coverage of key issues and trends. North America NGS Automation Market - Opportunity Analysis and Industry Forecast (2023-2030) |Speak To Analyst (https://www.meticulousresearch.com/speak-to-analyst/cp_id=5736) Contact Us: Meticulous Research® Email- [email protected] (mailto:[email protected]) Contact Sales- +1-646-781-8004 Connect with us on LinkedIn- Meticulous Research® | LinkedIn (https://www.linkedin.com/company/meticulous-research)

Meticulous Research®—a leading global market research company, published a research report titled, ‘Sequencing Kits Market by Type (Nucleic Acid Extraction & Amplification, Library Preparation, Control) Technology (NGS, Sanger) Application (Drug Discovery, Oncology, Reproductive Health, Infectious Diseases) End User - Global Forecast to 2030.’ According to this latest publication from Meticulous Research®, the sequencing kits market along with sequencing reagents is projected to reach $21.9 billion by 2030, at a CAGR of 15.3% during the forecast period. The growth of the sequencing kits market is driven by the increasing prevalence of cancer & genetic disorders, rising healthcare expenditures, increasing funding for research activities, the surge in genome mapping programs, the decreasing costs of sequencing procedures, the growing need for the early detection & prevention of diseases, technological advancements in sequencing products, the improving regulatory and reimbursement scenarios for NGS-based diagnostic tests, and government initiatives promoting the use of sequencing in clinical & research applications. However, the high costs of sequencing kits & reagents and the ethical & legal issues related to DNA sequencing-based diagnosis are factors restraining the growth of this market. Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5656 Additionally, developing portable sequencing technologies and increasing partnerships & collaborations among NGS product manufacturers to expand and improve product offerings are prominent trends in the sequencing kits market. Sequencing Kits & Reagents Market: Future Outlook The sequencing kits market along with sequencing reagents is segmented based on type [control kits & reagents, library preparation kits & reagents, nucleic acid extraction & amplification kits & reagents, sequencing kits & reagents, other kits & reagents], technology [next-generation sequencing, sanger sequencing, third & fourth-generation sequencing, other sequencing technologies] application [research applications (drug discovery, agricultural & animal research, other research applications), clinical applications (reproductive health, oncology, infectious diseases, other clinical applications)], end user [pharmaceutical & biotechnology companies, hospitals & diagnostic laboratories, academic & research institutes, other end users], and Geography. The study also evaluates industry competitors and analyzes the market at the regional and country levels. Speak To Analyst: https://www.meticulousresearch.com/speak-to-analyst/cp_id=5656 Quick Buy: https://www.meticulousresearch.com/Checkout/23122617 Geographic Review This research report analyzes major geographies and provides a comprehensive analysis of North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, Rest of Latin America) and the Middle East & Africa. Key Players The key players operating in the sequencing kits market along with sequencing reagents are Illumina, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), PerkinElmer, Inc. (U.S.), QIAGEN N.V. (Netherlands), Agilent Technologies, Inc. (U.S.), Pacific Biosciences of California, Inc. (U.S.), Danaher Corporation (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Oxford Nanopore Technologies Plc. (U.K.), 10X Genomics, Inc. (U.S.), and Beijing Genomics Institute (BGI) (China). Key questions answered in the report: Which are the high-growth market segments in terms of type, technology, application, end user, and region/country? What was the historical market size for sequencing kits market globally? What are the market forecasts and estimates for the period 2023–2030? What are the major drivers, restraints, challenges, and opportunities in the global sequencing kits market? Who are the major players in the global sequencing kits market? How is the competitive landscape, and who are the market leaders in the global sequencing kits market? What are the recent developments in the sequencing kits market? What strategies are adopted by the major players in the sequencing kits market? What are the geographical trends and high-growth regions/countries? Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5656 Contact Us: Meticulous Research® Email- [email protected] Contact Sales- +1-646-781-8004 Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research

Next Generation Sequencing (NGS) Informatics Market to be Worth $4.3 Billion by 2030 Meticulous Research®-a leading global market research company, published a research report titled, 'Next Generation Sequencing (NGS) Informatics Market by Offering (Data Analysis, Interpretation & Reporting, Storage & Computing, LIMS), Application (Diagnostic, Drug Discovery, Precision Medicine, Biomarker Discovery) End User - Global Forecast to 2030.' According to this latest publication from Meticulous Research®, the next generation sequencing (NGS) informatics market is projected to reach $4.3 billion by 2030, at a CAGR of 15.4% during the forecast period. The growth of the NGS informatics market is driven by increasing R&D investments by pharmaceutical and biotechnology companies, the rising prevalence of cancer and genetic disorders, the growing utilization of NGS in disease diagnostics and precision medicine, technological advancements in NGS informatics solutions, and government initiatives supporting large-scale genomic sequencing projects. However, data confidentiality concerns restrain the growth of this market. Request Free Report Sample Now: https://www.meticulousresearch.com/request-sample-report/cp_id=3483 The increasing adoption of NGS informatics tools among hospitals and clinical laboratories and the growing use of bioinformatics and genomic data management solutions for large-scale data analysis and interpretation are expected to create growth opportunities for the players operating in the NGS informatics market. However, the lack of skilled professionals required to operate NGS Informatics tools is a major challenge for market growth. Next Generation Sequencing (NGS) Informatics Market: Future Outlook The next generation sequencing (NGS) informatics market is segmented based on Offering (Software [Data Analysis Software, Data Interpretation and Reporting Tools, Data Storage and Computing Tools, Laboratory Information Management Systems {LIMS}], Deployment Mode [Web and Cloud-based, On-premise], NGS Informatics Services); Application (Disease Diagnoses, Biomarker Discovery, Drug Discovery, Precision Medicine, Agriculture and Animal Research); End User (Pharmaceutical & Biotechnology Companies, Hospitals and Diagnostic Laboratories, Academic & Research Institutes, Other End Users); and Geography. The study also evaluates industry competitors and analyzes the market at the regional and country levels. To gain more insights into the market with a detailed table of content and figures, click here: https://www.meticulousresearch.com/product/ngs-informatics-market-3483 Based on application, the next generation sequencing (NGS) informatics market is segmented into disease diagnoses, biomarker discovery, drug discovery, precision medicine, agriculture, and animal research. In 2023, the drug discovery segment is expected to account for the largest share of the next generation sequencing (NGS) informatics market. The rapidly decreasing cost of sequencing per base, the potential of NGS informatics solutions to reveal a large number of mutations linked to genetic diseases and identify target genes for possible drug discovery, the increasing adoption of sequencing in pharmaceutical and biotechnological companies generating large volumes of data for research purposes, and the increasing R&D expenditure for new drug discovery are factors contributing to the significant market share of this segment. Quick Buy - Next Generation Sequencing (NGS) Informatics Market to be Worth $4.3 Billion by 2030 https://www.meticulousresearch.com/Checkout/14671982 Geographic Review This research report analyzes major geographies and provides a comprehensive analysis of the market in North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, and Rest of Latin America) and the Middle East & Africa. Key Players The key players operating in the next generation sequencing (NGS) informatics market are Illumina, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Qiagen N.V. (Netherlands), Agilent Technologies, Inc. (U.S.), Sapio Sciences, LLC (U.S.), DNASTAR, Inc. (U.S.), Fabric Genomics, Inc. (U.S.), Partek Incorporated (U.S.), and DNAnexus, Inc. (U.S.). Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=3483 Meticulous Market Research Inc. 1267 Willis St, Ste 200 Redding, California, 96001, U.S. USA: +1-646-781-8004 Europe : +44-203-868-8738 APAC: +91 744-7780008 Email- [email protected] Visit Our Website: https://www.meticulousresearch.com/ Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research Content Source: https://www.meticulousresearch.com/pressrelease/187/ngs-informatics-market-2030